## 참고문헌

1.  2010 결핵관리지침
2.  2012 결핵관리지침
3.  Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, et al. (2011) The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices. PLoS Med 8(3): e1001012.
4.  Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994;271:698-702.
5.  Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154–8.
6.  Jin BW, Hong YP, Kim SJ. A contact study to evaluate the BCG vaccination programme in Seoul. Tubercle 1989;70:241–8.
7.  al-Kassimi FA, al-Hajjaj MS, al-Orainey IO, Bamgboye EA. Does the protective effect of neonatal BCG correlate with vaccine-induced tuberculin reaction? Am J Respir Crit Care Med 1995;152:1575–8.
8.  대한소아과학회. 예방접종지침서. 제10판 [BCG (Bacille Calmette-Guerin) 백신], 서울, 대한소아과학회. 2021;80-97.
9.  https://www.gov.uk/government/publications/tuberculosis-thegreen-book-chapter-32
10. WHO. Issues relating to the use of BCG in immunization programmes. WHO/V&B/99.23.
11. WHO. The immunological basis for immunization series : Tuberculosis. WHO/EPI/GEN/93.15.
12. UK guidance on best practice in vaccine administration. 2001.
13. Simpson G. BCG vaccine in Australia. Aust Prescr 2003;26:144–6.
14. Cuello-García CA, Pérez-Gaxiola G, Jiménez Gutiérrez C. Treating BCG-induced disease in children. Cochrane Database Syst Rev 2013; 1:CD008300.

VII. 소아청소년 결핵 <PAGE>295